Cas no for 138926-19-9,IbandronateSodium ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich

Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

Home > CAS No. Inquiry > 138926-19-9

138926-19-9

[CAS Name] IbandronateSodium

[Formula] C9H24NNaO8P2

Search Products Post Sourcing Request

Basica Info

[CAS Name]IbandronateSodium
[Alias]ibandronate sodium; [1-Hydroxy-3-(methylpentylamino)-propylidene]bisphosphonic acid sodium salt; sodium hydrogen {1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonate hydrate
[Number]138926-19-9
[EINECS]
[Formula]C9H24NNaO8P2
[Molecular weight]359.2261

[Boiling point]587.8°C at 760 mmHg
[Density]2.88E-16mmHg at 25°C
[Flash point]309.3°C

138926-19-9 Suppliers

Company

Main Products

ZF Polpharma S.A.

Ibandronate sodium

Long experience in in-house commercial manufacturing
Extensive portfolio of Bisphosphonates
Technology not generating genotoxic impurities
Injection grade

Status	Commercial
Therapeutic cat.	Musculo-skeletal
Polymorphic form	Monohydrate Form B
CAS No.	138926-19-9
Injectable Form	Injectable
EU DMF readiness
CEP
CHINESE DMF
JAPANESE DMF
KOREAN DMF
CADIFA
US DMF readiness

Drug description

Ibandronate is a bisphosphonate medicine that alters bone formation and breakdown in the body. This can slow bone loss and may help prevent bone fractures. Ibandronate is used to treat or prevent osteoporosis in women after menopause. Ibandronate may also be used for purposes not listed in this medication guide.

Disclaimer: Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).

Send Inquiry

Previous page 1 2 3 4 Next page